| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Author’s Response
|
Rao, Niranjan
|
|
2011
|
51 |
5 |
p. 784-784
|
article
|
| 2 |
Biliary Excretion of Ximelagatran and Its Metabolites and the Influence of Erythromycin Following Intraintestinal Administration to Healthy Volunteers
|
Matsson, Elin M.
|
|
2011
|
51 |
5 |
p. 770-783
|
article
|
| 3 |
Effect of Antipsychotic Medications on Glucose and Lipid Levels
|
Chaggar, Parminder S.
|
|
2011
|
51 |
5 |
p. 631-638
|
article
|
| 4 |
Effect of Citrus Juice and SLCO2B1 Genotype on the Pharmacokinetics of Montelukast
|
Mougey, E. B.
|
|
2011
|
51 |
5 |
p. 751-760
|
article
|
| 5 |
Effect of Hepatic or Renal Impairment on Eltrombopag Pharmacokinetics
|
Bauman, John W.
|
|
2011
|
51 |
5 |
p. 739-750
|
article
|
| 6 |
Effects of Food on the Pharmacokinetics of Edoxaban, an Oral Direct Factor Xa Inhibitor, in Healthy Volunteers
|
Mendell, Jeanne
|
|
2011
|
51 |
5 |
p. 687-694
|
article
|
| 7 |
Evaluation of Single-Point Sampling Strategies for the Estimation of Moclobemide Exposure in Depressive Patients
|
Ignjatovic, Anita Rakic
|
|
2011
|
51 |
5 |
p. 661-671
|
article
|
| 8 |
In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
|
Shoaf, Susan E.
|
|
2011
|
51 |
5 |
p. 761-769
|
article
|
| 9 |
Modeling Dropout From Adverse Event Data: Impact of Dosing Regimens Across Pregabalin Trials in the Treatment of Generalized Anxiety Disorder
|
Lalovic, Bojan
|
|
2011
|
51 |
5 |
p. 706-718
|
article
|
| 10 |
Optimizing Drug Development and Use in Patients With Kidney Disease
|
Nolin, Thomas D.
|
|
2011
|
51 |
5 |
p. 628-630
|
article
|
| 11 |
Pharmacokinetics of 5-Aminofluorescein-Albumin, a Novel Fluorescence Marker of Brain Tumors During Surgery
|
Ding, Reinhard
|
|
2011
|
51 |
5 |
p. 672-678
|
article
|
| 12 |
Pharmacokinetics of Clofarabine in Patients With High-Risk Inherited Metabolic Disorders Undergoing Brain-Sparing Hematopoietic Cell Transplantation
|
Long-Boyle, Janel
|
|
2011
|
51 |
5 |
p. 679-686
|
article
|
| 13 |
Pharmacokinetics of Dexrazoxane in Subjects With Impaired Kidney Function
|
Brier, Michael E.
|
|
2011
|
51 |
5 |
p. 731-738
|
article
|
| 14 |
Population Approach for Exposure-Response Modeling of Golimumab in Patients With Rheumatoid Arthritis
|
Hu, Chuanpu
|
|
2011
|
51 |
5 |
p. 639-648
|
article
|
| 15 |
Safety, Pharmacokinetic, and Pharmacodynamic Evaluations of PI-2301, a Potent Immunomodulator, in a First-in-Human, Single-Ascending-Dose Study in Healthy Volunteers
|
Kovalchin, Joseph
|
|
2011
|
51 |
5 |
p. 649-660
|
article
|
| 16 |
Safety, Tolerability, and Pharmacokinetics of Eliglustat Tartrate (Genz-112638) After Single Doses, Multiple Doses, and Food in Healthy Volunteers
|
Peterschmitt, M. Judith
|
|
2011
|
51 |
5 |
p. 695-705
|
article
|
| 17 |
Skin Cleansers: The Risks of Chlorhexidine
|
Sivathasan, Niroshan
|
|
2011
|
51 |
5 |
p. 785-786
|
article
|
| 18 |
The Intravenous Anesthetic Propofol Inhibits Human L-Type Calcium Channels by Enhancing Voltage-Dependent Inactivation
|
Fassl, Jens
|
|
2011
|
51 |
5 |
p. 719-730
|
article
|
Journal description